samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Aptar CSP’s Technologies Activ-Film™ Technology Protects New At-Home Prescription and OTC COVID-19 Tests

Aptar Pharma



Auburn, AL, April 28, 2021 – Aptar CSP Technologies, a leader in material science and active packaging solutions (part of AptarGroup, Inc.), announced its Activ-FilmTM technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

The tests were developed by a leading manufacturer of diagnostic healthcare solutions and offer prescription and OTC (Over the Counter) COVID-19 at-home testing options without the need to visit a doctor’s office.



Aptar CSP’s Activ-FilmTM technology is integrated into the dipstick of the diagnostic kits to protect against moisture and other environmental conditions that could otherwise impact test accuracy. Activ-FilmTM leverages Aptar’s proprietary 3-Phase Activ-PolymerTM platform technology, which provides a broad spectrum of customized and highly-engineered solutions in a variety of configurations, such as Activ-VialTM for housing diagnostics strips and dipsticks, and Activ-TabTM, which is integrated within diagnostic cassettes. This material science-based active packaging technology currently protects a range of lateral flow, molecular, and electrochemical diagnostic test kits on the market today, including Quidel® Corporation’s QuickVue® Influenza and COVID-19 tests.

“As we continue to navigate through the COVID-19 crisis, this game-changing solution will help meet the urgent demand for COVID-19 testing in communities around the world,” said Badre Hammond, Vice President Commercial Operations, Aptar CSP Technologies. “We are committed to leveraging our material science expertise to enable our partners to meet the ongoing need for innovative healthcare solutions that help improve and save lives. This is another example of the value we bring to the market when sensitive diagnostic elements need protection.”

More information about the new at-home COVID-19 tests is available on the FDA website.
phone +33 (0)13 917 2020
email info.pharma@aptar.com
web www.aptar.com/pharma
email 36-38 Rue de la Princesse, 78431 Louveciennes
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Language Weaver now available for ServiceNow customers

RWS, the world’s leading provider of technology-enabled language, content management, and intellectual property services, has released a new Language Weaver Connector for ServiceNow
More info >>


White Papers

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement